Skip to content

Internet treatment of alcohol dependence in primary care

Internet-based Treatment of Alcohol Dependence in primary care - a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN69957414
Enrollment
260
Registered
2018-06-07
Start date
2017-08-24
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol dependence Mental and Behavioural Disorders Alcohol dependence

Interventions

The participants will first do an application and read information about the study. After this the participants will provide their concent and answer a number of questionnaires. If inclusion criteria

Sponsors

Addiction Centre Stockholm (Beroendecentrum Stockholm)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Alcohol dependence according to ICD-10 criteria, hazardous alcohol consumption 2. Male and female, >18 years of age 3. Housing in Stockholm county

Exclusion criteria

Exclusion criteria: 1. Severe mental illness 2. Severe dependence in need of specialist treatment 3. Abuse or dependence of other substances apart from alcohol and/or nicotine 4. Severe somatic illness 5. Non-Swedish speaking

Design outcomes

Primary

MeasureTime frame
Change of weekly alcohol consumption and number of heavy drinking days measured by the Time line follow back instrument.

Secondary

MeasureTime frame
1. Change of degree of alcohol dependence ICD 10 criteria is measured using questionnaires at baseline, 3 and 12months 2. Change of consequences of drinking AUDIT scores is measured using questionnaires at baseline, 3 and 12 months 3. Change of symptoms of anxiety and depression HAD scores is measured using questionnaires at baseline, 3 and 12 months 4. Change of quality of life EQ5D is measured using questionnaires at baseline, 3 and 12 months 5. Change of levels of phosphatidylethanol (PEth) are measured using bloodsample at baseline, 3 and 12 months 6. Change of levels of aspartate aminotransferase (ASAT) are measured using bloodsample at baseline, 3 and 12 months 7. Change of levels of alanine aminotransferase (ALAT) are measured using bloodsample at baseline, 3 and 12 months 8. Change of levels of gamma-glutamyltransferase (GGT) are measured using bloodsample at baseline, 3 and 12 months 9. Patients’ satisfaction with treatment CSQ is measured using questionnaire at 3 months

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 28, 2026